Allen Lew, a recently appointed director of Raffles Medical Group, acquired 100,000 shares at $1.35 each on July 27. A day earlier, he had bought another 100,000 shares at $1.30 each. His 200,000 shares is equivalent to 0.011% of the company.

Lew, a longtime stalwart at Singapore Telecommunications, joined Raffles Medical on Oct 28, 2020, as director. Lew bought the shares just after Raffles Medical Group reported better results before the market opened on July 26.

For the 1HFY2021 ended June 30, the company reported earnings more than doubled to nearly $39.5 million from $17.2 million in 1HFY2020. Revenue in 1HFY2021 rose 42.4% to $343.8 million from 1HFY2020 as Raffles Medical was one of the leading companies contracted by the government to provide Covid-19 related services. These included operating various vaccination centres and providing swabbing services.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook